A Resistance-Evading Antibiotic for Treating Anthrax
Dallas E. Hughes(NovoBiotic Pharmaceuticals), Kim Lewis(Northeastern University), Markus Weingarth(University of Applied Sciences Utrecht), Henry S. Heine(University of Florida), Rhythm Shukla(Utrecht University), Jennifer L. Peel(The University of Texas Medical Branch at Galveston), Losee L. Ling(NovoBiotic Pharmaceuticals), William S. Lawrence(The University of Texas Medical Branch at Galveston), Rosan de Winter(Utrecht University), Hensel Martha, Whorton Elbert(The University of Texas Medical Branch at Galveston), Nitti Niiti(NovoBiotic Pharmaceuticals), Peoples Aaron(NovoBiotic Pharmaceuticals), Harold D. MacGillavry(Amsterdam Neuroscience)
Cited by 1
Related Papers
Definitions and guidelines for research on antibiotic persistence
|Nature Reviews Microbiology|2019|1.3k
Tackling antibiotic resistance
|Nature Reviews Microbiology|2011|1.1k
Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
|PLoS Biology|2010|772